Home › Trial NCT04230499
Trial of eRapa to Prevent Progression in Familial Adenomatous Polyposis Patients Under Active Surveillance
- Trial IDNCT04230499
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorRapamycin Holdings Inc.
- Enrollment30
- Start date2021-01-18
- ConditionsFamilial Adenomatous Polyposis
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.